Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0001193125-26-039598

Chief Commercial Officer acquired 115,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Wiley Matthew T. · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-03 Grant or award : show line 1 in the form +115,000 115,000 D
Loading xslF345X05/ownership.xml…